Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
about
Heparin for pregnant women with acquired or inherited thrombophiliasThrombophilia and pregnancyLow-molecular-weight heparins in pregnancy.Factors associated with uterine artery Doppler anomalies in patients with preeclampsia.Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT.Outcome of pregnancy in women with hereditary thrombophilia.The endocrinology of pre-eclampsia.Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a prior history - an open-label randomised trial (the EPPI trial): study protocol.Individual risk assessment of adverse pregnancy outcome by multivariate regression analysis may serve as basis for drug intervention studies: retrospective analysis of 426 high-risk patients including ethical aspectsThe impact of close surveillance on pregnancy outcome among women with a prior history of antepartum complications attributed to thrombosis: a cohort study.Preventing thrombophilia-related complications of pregnancy.Inherited and acquired thrombophilias.Overview of low molecular weight heparin for preventative treatment of adverse obstetric outcomes related to abnormal placentation.Heparin for patients with growth restricted fetus: a prospective randomized controlled trial.Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology.Maternal segregation of the Dutch preeclampsia locus at 10q22 with a new member of the winged helix gene family.Low molecular weight heparin treatment during subsequent pregnancies of women with inherited thrombophilia and previous severe pregnancy complications.Toward optimal set of single nucleotide polymorphism investigation before IVF.Can heparin prevent adverse pregnancy outcome?
P2860
Q24248689-90568B85-E5A1-4026-BDCB-CA2DCE1D6EF8Q24801115-53199091-8914-426A-BA84-ACE3E026918EQ30828885-491D30AA-77D9-4F0A-92DB-972788169D58Q33444914-B72CB304-002A-47D0-820B-A367E31AA5DEQ34236115-268EE472-1683-4BD8-B96E-775DE50BB749Q34360385-6A1E1925-8F69-4E8B-BA8B-ADA16AC7E94AQ34920656-CB21C8EB-7446-47B9-948D-4D547642AD83Q36201389-57EC0B05-8895-4107-860A-1DCA141447A3Q36927599-B19D36FB-D9EA-4581-8250-780180E456A1Q37015306-81887BAC-D0AE-4FF7-A374-DADB99D391A9Q37810268-8D162F31-C2B6-46B8-A788-03D0493AFA27Q38125276-3C7B2EA7-C583-4BFA-B7DB-08AEACA41CECQ38206136-BACA8458-E7A7-43FD-80A0-1E7C1F3504C1Q43232972-7AD5D024-13AB-4131-BA54-E338F2CE26D9Q46396909-7238C9F7-3BD3-47D6-B22B-828DB96B988AQ46418228-1ECB3545-DC7F-4628-B275-6828FE4AD626Q47396374-5F3B4761-F87A-4172-80F6-31F921843CBDQ47659103-721CB390-281F-471E-AF69-706C4171E4E9Q58778341-BC1B0577-F29B-4A09-A394-40EB42638AA7
P2860
Low-molecular-weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Low-molecular-weight heparin c ...... triction: a preliminary study.
@en
Low-molecular-weight heparin c ...... triction: a preliminary study.
@nl
type
label
Low-molecular-weight heparin c ...... triction: a preliminary study.
@en
Low-molecular-weight heparin c ...... triction: a preliminary study.
@nl
prefLabel
Low-molecular-weight heparin c ...... triction: a preliminary study.
@en
Low-molecular-weight heparin c ...... triction: a preliminary study.
@nl
P2093
P921
P1476
Low-molecular-weight heparin c ...... triction: a preliminary study.
@en
P2093
P356
10.1016/S0301-2115(98)00083-9
P577
1998-09-01T00:00:00Z